Parkinson hastalığı için biyobelirteçlerdeki gelişmeler: Moleküler patolojiden hassas tanıya kadar.
Advances in biomarkers for Parkinson's disease: from molecular pathology to precision diagnostics.
DOI: 10.1631/jzus.b2500789PMID: 42529883
Advances in biomarkers for Parkinson's disease: from molecular pathology to precision diagnostics.
DOI: 10.1631/jzus.b2500789PMID: 42529883
Sarsasapogenin Improves Pathological Phenotypes in MPTP/MPP<sup>+</sup>-Induced Parkinson's Disease Models: Synergistic Actions of Neurite Outgrowth, Neurotransmitter Modulation, and Anti-Inflammation.
DOI: 10.31083/jin50683PMID: 42530039
Extracellular Vesicle-Mediated Delivery of VEGF and NGF Protects Dopaminergic Neurons in 6-OHDA-Induced Parkinson's Disease Models.
DOI: 10.31083/jin50932PMID: 42530044
Medial accessory olivary nucleus asymmetry and its selective degeneration in Parkinson's disease: A human neuropathological study.
DOI: 10.5414/np301741PMID: 42544520
Frequency and types of motor fluctuations in patients presenting with advanced Parkinson's disease.
DOI: 10.12669/pjms.42.7.15138PMID: 42555468
Dental Caries Experience in Older Adults With Parkinson's Disease: A Systematic Review and Meta-Analysis.
DOI: 10.1111/scd.70230PMID: 42572491
Clinicopathologic mismatch in young-onset parkinsonism: Multiple system atrophy masquerading as a neurotransmitter synthesis disorder.
DOI: 10.5414/np301756PMID: 42572865
Subjective Outcomes of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: Insights from Patients and Caregivers.
DOI: 10.4103/aian.aian_1013_25PMID: 42574195
Expression of concern: "Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838].
DOI: 10.1016/j.biopha.2026.119723PMID: 42477980
Distinct brain susceptibility alteration pattern in Parkinson's disease with drooling: evidence from quantitative susceptibility mapping.
DOI: 10.21037/qims-2026-0746PMID: 42582546
Peripheral nervous system involvement in Parkinson's disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications.
DOI: 10.1016/j.neubiorev.2026.106840PMID: 42385962
An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease.
DOI: 10.1016/j.ejps.2026.107597PMID: 42386013
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.